Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02126101

Ligand	Ligand name	Chain	PDB	Tanimoto
A79	N-{1-BENZYL-(2S,3S)-2,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE	A	1HVC	0.7
A79	N-{1-BENZYL-(2S,3S)-2,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE	A	1HVK	0.7
2S3	(2S)-2-(1H-indol-3-yl)pentanoic acid	B	3C6P	0.7
AG1	RUTHENIUM PYRIDOCARBAZOLE	A,B	2JLD	0.71
A78	N-{1-BENZYL-3-HYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE	A	1HVJ	0.72
A85	N-{1-BENZYL-2,2-DIFLUORO-3,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE	A,B	1DIF	0.71
4ST	1,2,3,4-TETRAHYDROGEN-STAUROSPORINE	A	2J0J	0.75
4ST	1,2,3,4-TETRAHYDROGEN-STAUROSPORINE	B	2J0M	0.75
4ST	1,2,3,4-TETRAHYDROGEN-STAUROSPORINE	A,B	2J0K	0.75
4ST	1,2,3,4-TETRAHYDROGEN-STAUROSPORINE	A	1YVJ	0.75
4ST	1,2,3,4-TETRAHYDROGEN-STAUROSPORINE	A,B,C	2HZ4	0.75
2AH		B	2CEM	0.74
2S2	(2S)-2-(1H-indol-3-yl)hexanoic acid	B	3C6O	0.71
A76	N-{1-BENZYL-(2R,3R)-2,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE	B	1HVL	0.7
4AH		B	2CEN	0.73
3IO	3-(1H-INDOL-3-YL)-2-OXOPROPANOIC ACID	A,B,C,D	1XES	0.71
3IO	3-(1H-INDOL-3-YL)-2-OXOPROPANOIC ACID	B,C,D	1XET	0.71
4FW	4-FLUOROTRYPTOPHANE	A	1RM9	0.71
567	2-[[(2R)-1-[[(2S)-5-amino-1-[(4-carbamimidoylphenyl)methylamino]-1,5-dioxo-pentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxo-propan-2-yl]sulfamoyl]ethanoic acid	H,L	2ZWL	0.71
2S8	(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid	B	3C6N	0.75
A77	N-{1-BENZYL-(2R,3S)-2,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE	A	1HVI	0.7
A77	N-{1-BENZYL-(2R,3S)-2,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE	A	1HVS	0.7
6MR	N-[(4'-IODOBIPHENYL-4-YL)SULFONYL]-D-TRYPTOPHAN	A,B	2OW0	0.71
4IN	4-AMINO-L-TRYPTOPHAN	A,B	2HXX	0.72
4IN	4-AMINO-L-TRYPTOPHAN	A	1OXF	0.72
1IN	1-[2-HYDROXY-4-(2-HYDROXY-5-METHYL-CYCLOPENTYLCARBAMOYL)5-PHENYL-PENTYL]-4-(3-PYRIDIN-3-YL-PROPIONYL)-PIPERAZINE-2-CARBOXYLIC ACID TERT-BUTYLAMIDE	B	2BPV	0.73
1IN	1-[2-HYDROXY-4-(2-HYDROXY-5-METHYL-CYCLOPENTYLCARBAMOYL)5-PHENYL-PENTYL]-4-(3-PYRIDIN-3-YL-PROPIONYL)-PIPERAZINE-2-CARBOXYLIC ACID TERT-BUTYLAMIDE	B	2BPW	0.73
5BN	5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE	A	1P2A	0.71
5ZA	(5Z)-2-[(1S,2R)-1-AMINO-2-HYDROXYPROPYL]-5-[(4-AMINO-1H-INDOL-3-YL)METHYLENE]-3-(2-HYDROXYETHYL)-3,5-DIHYDRO-4H-IMIDAZOL-4-ONE	A	1OXF	0.7